Taking Ozempic? A routine eye exam could help you understand your risk for vision loss.
THE SO WHAT
Emerging links between GLP-1 drugs and rare eye disease risk put more weight on longitudinal monitoring and data-sharing between endocrinology and ophthalmology. Healthcare operators should treat this as a nudge to tighten real-world evidence pipelines and patient follow-up, not as a reason to pause metabolic programs.
READ THE SOURCE
MORE FROM THE WIRE
Tech & InnovationMicrosoft Office suddenly needs to reactivate? A bad update might be why
A single out-of-band update forcing surprise Office reactivations is a reminder that SaaS license state is now a production dependency. If you’re running Microsoft 365 at scale, treat update channels and activation telemetry as part of your incident playbook, not an afterthought.
Tech & InnovationOld Dominion Freight Line names new board member
A former Waste Connections CEO joining Old Dominion’s board is another data point in freight and logistics consolidating leadership talent around network optimization and asset utilization. If you’re in adjacent transport or logistics tech, assume boardrooms are primed for conversations about automation, pricing power, and M&A.
Tech & InnovationLanterns episode 8 trailer spawns major new fan theory about John Stewart's fate
Fan theories spinning off a single trailer underscore how much of streaming’s engagement loop now lives in speculation, not just episodes. Studios should be treating teaser design and controlled leaks as part of a deliberate narrative ops function, not just marketing.
Tech & InnovationThe SaaSpocalypse that wasn’t, with Atlassian CEO Mike Cannon-Brookes
Atlassian’s posture that the “SaaSpocalypse” hasn’t arrived reflects a split: horizontal tools are under pricing pressure, but deeply embedded workflow platforms still have leverage. For operators, the move is to either become indispensable infrastructure in a few workflows or accept that AI-assisted build will compress your pricing power.